Red Herring Editor Jumps Into New Overhyped Trend: Biotech
from the follow-the-hype-trail dept
Jason Pontin, former high profile editor of the now out of business Red Herring, has moved onto a new gig, as editor of a new magazine about the biotech industry. Yes, this sounds like someone moving from one overhyped industry into another - but Pontin insists he's learned his lessons from Red Herring, and the magazine, the Acumen Journal, won't make the same mistakes. It's easy to say that early on, of course.
Thank you for reading this Techdirt post. With so many things competing for everyone’s attention these days, we really appreciate you giving us your time. We work hard every day to put quality content out there for our community.
Techdirt is one of the few remaining truly independent media outlets. We do not have a giant corporation behind us, and we rely heavily on our community to support us, in an age when advertisers are increasingly uninterested in sponsoring small, independent sites — especially a site like ours that is unwilling to pull punches in its reporting and analysis.
While other websites have resorted to paywalls, registration requirements, and increasingly annoying/intrusive advertising, we have always kept Techdirt open and available to anyone. But in order to continue doing so, we need your support. We offer a variety of ways for our readers to support us, from direct donations to special subscriptions and cool merchandise — and every little bit helps. Thank you.
–The Techdirt Team
Reader Comments
Subscribe: RSS
View by: Time | Thread
Heh
In pharmaceutical research, 99.9% of research fails. The 0.1% that succeeds is handed off to production, so the researchers lose their jobs anyway. If you want to go into the biotech industry, you're looking at a life of bouncing from one failed company to the next. Unless you have a PhD in biology, and unless you think that squiggly molecules are the purpose of your life, it is not a fulfilling career.
[ link to this | view in chronology ]